Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amany M. Ismail"'
Publikováno v:
Inorganic Chemistry Communications. 106:217-223
The preparation of new complexes containing 2-amino-4,6-mercaptotriazine (HAT) [Zn(AT)2(H2O)2], [Zn(bpy)(AT)Cl(H2O)], [Zn(PPh3)2(AT)Cl(H2O)] and cis-[Mo2O5(AT)2] is reported. The structures of these complexes are discussed using IR, NMR, UV–Vis, an
The syntheses of new zinc(II), palladium(II), platinum(II) and silver(I) complexes of indol-3-acetic acid (HIAA) as a primary chelate and N,N- (2,2’-bipyridyl; bpy) or P- (triphenylphosphine; PPh3) as secondary chelate are reported. The molecular s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff985bb163c91993517a46d34c1b457
Publikováno v:
Journal of Molecular Structure. 1200:127088
Inorganic medicinal chemistry has been focused for many years on the study of the anticancer activity of transition metal complexes, especially those based on the Pt(II) ion. Since the 1,3,5-triazine molecule has significant biological activity, we t
Autor:
Mohamed A. Ghoneim, Osama E. Gheith, Mohamed A. Sobh, Hussein Sheashaa, Amany M. Ismail, Mohamed A. Bakr, Khalid Farouk El-Dahshan
Publikováno v:
American Journal of Nephrology. 25:221-225
Background/Aims: The long-term evaluation of basiliximab induction therapy has not been addressed yet. We aim to evaluate its long-term effects in living related donor kidney transplantation. Methods: 100 adult recipients with their first kidney allo
Autor:
Mohamed A. Fouda, Khalid Farouk El-Dahshan, Mohamed A. Sobh, Mohamed A. Ghoneim, Amany M. Ismail, Mohamed A. Bakr, Hussein Sheashaa
Publikováno v:
International urology and nephrology. 39(1)
The aim of this work is to determine the long-term therapeutic benefit(s) of daclizumab induction therapy with triple immunosuppressive protocols including prednisolone, cyclosporine microemulsion (CsA), and mycophenolate mofetil (MMF) in the living
Publikováno v:
Journal of nephrology. 16(3)
The aim of this work was to investigate the benefit of basiliximab induction therapy in living-related-donor kidney transplantation.One hundred adult recipients of a first kidney allograft were randomized into two treatment groups, one to receive bas